CVE:THCX Hydropothecary (THCX) Stock Price, News & Analysis C$5.30 +0.33 (+6.64%) As of 06/21/2018 Add Compare Share Share Stock Analysis Stock Analysis About Hydropothecary Stock (CVE:THCX) Get Hydropothecary alerts:Sign Up Key Stats Today's RangeC$5.00▼C$5.3750-Day RangeC$5.30▼C$5.3052-Week RangeC$1.10▼C$5.42Volume5.38 million shsAverage Volume2.35 million shsMarket CapitalizationC$949.11 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview The Hydropothecary Corporation, together with its subsidiaries, produces and distributes medical marijuana products. The company is headquartered in Gatineau, Canada. Read More Receive THCX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hydropothecary and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. THCX Stock News HeadlinesAXS CANNABIS ETF ESTIMATED CASH (^THCX-EU)April 16, 2023 | finance.yahoo.comThe Hydropothecary Corporation (HEXO.TO)February 25, 2023 | uk.finance.yahoo.comHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. One day it's a ceasefire, the next it's bombs again. The back and forth may be masking a bigger story most investors are missing. See the real reason this conflict may never fully end. | Banyan Hill Publishing (Ad)AXS Cannabis ETF (THCX)February 17, 2023 | finance.yahoo.comOutlook on the Medical Cannabis Global Market to 2027 - Emergence of Cannabis Legalization Presents Opportunities USA - English - USA - English - PR NewswireAugust 16, 2022 | prnewswire.comThe Worldwide Medical Cannabis Industry is Expected to Reach $24.8 Billion by 2027 - ResearchAndMarkets.com - Business WireAugust 15, 2022 | businesswire.comBedel Financial Consulting, Inc. Buys Innovator S&P 500 Power Buffer ETF - GuruFocus.comAugust 3, 2021 | gurufocus.comOptimum Investment Advisors Bu - GuruFocus.comAugust 2, 2021 | gurufocus.comSee More Headlines THCX Stock Analysis - Frequently Asked Questions How have THCX shares performed this year? Hydropothecary's stock was trading at C$5.30 at the beginning of the year. Since then, THCX shares have increased by 0.0% and is now trading at C$5.30. How do I buy shares of Hydropothecary? Shares of THCX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Hydropothecary own? Based on aggregate information from My MarketBeat watchlists, some other companies that Hydropothecary investors own include Canopy Growth (WEED), Aurora Cannabis (ACB), Aphria (APHA), Canopy Growth (CGC), Cronos Group (CRON), Riot Platforms (RIOT). Industry, Sector and Symbol Stock ExchangeCVE SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolCVE:THCX CIKN/A Webwww.thehydropothecary.com Phone+1-416-7504949FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares179,077,000Free FloatN/AMarket CapC$949.11 million OptionableNot Optionable BetaN/A 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (CVE:THCX) was last updated on 9/28/2026 by MarketBeat.com Staff. From Our PartnersWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredRothschilds and BlackRock are buying this high yield gold playMost stocks yield under 2%. Even gold stocks average less than 1%. One gold security, backed by one of the wor...Golden Portfolio | SponsoredThe next convergence is hereIn 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This pa...Digest Publishing | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Hydropothecary Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Hydropothecary With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.